Oxford Study Confirms Astra Covid Shot’s Response in Elderly

  • Astra partner sees late-stage Covid data in coming weeks
  • Older adults are at highest risk of severe illness from virus
Oxford Study Confirms Astra Vaccine Response in Older Adults
Lock
This article is for subscribers only.

The University of Oxford confirmed that the Covid-19 vaccine it’s developing with AstraZeneca Plc produced strong immune responses in older adults in an early study, with key findings from the last phase of tests expected in the coming weeks.

The results, published Thursday in The Lancet medical journal, shed more light on preliminary data released in recent months showing the experimental shot generated an immune response in the elderly, who are at highest risk of severe illness.